209 related articles for article (PubMed ID: 21306646)
1. Enhanced immunogenicity of pneumococcal surface adhesin A (PsaA) in mice via fusion to recombinant human B lymphocyte stimulator (BLyS).
Gor DO; Ding X; Li Q; Sultana D; Mambula SS; Bram RJ; Greenspan NS
Biol Direct; 2011 Feb; 6():9. PubMed ID: 21306646
[TBL] [Abstract][Full Text] [Related]
2. Enhanced immunogenicity of pneumococcal surface adhesin A by genetic fusion to cytokines and evaluation of protective immunity in mice.
Gor DO; Ding X; Li Q; Schreiber JR; Dubinsky M; Greenspan NS
Infect Immun; 2002 Oct; 70(10):5589-95. PubMed ID: 12228286
[TBL] [Abstract][Full Text] [Related]
3. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
Lu J; Sun T; Wang D; Dong Y; Xu M; Hou H; Kong FT; Liang C; Gu T; Chen P; Sun S; Lv X; Jiang C; Kong W; Wu Y
Immunol Invest; 2015; 44(5):482-96. PubMed ID: 26107747
[TBL] [Abstract][Full Text] [Related]
4. Comparison of four adjuvants revealed the strongest protection against lethal pneumococcal challenge following immunization with PsaA-PspA fusion protein and AS02 as adjuvant.
Chen X; Li B; Yu J; Zhang Y; Mo Z; Gu T; Kong W; Zhang Y; Wu Y
Med Microbiol Immunol; 2019 Apr; 208(2):215-226. PubMed ID: 30707297
[TBL] [Abstract][Full Text] [Related]
5. TACI-BLyS signaling via B-cell-dendritic cell cooperation is required for naive CD8+ T-cell priming in vivo.
Diaz-de-Durana Y; Mantchev GT; Bram RJ; Franco A
Blood; 2006 Jan; 107(2):594-601. PubMed ID: 16195331
[TBL] [Abstract][Full Text] [Related]
6. Deficient TACI expression on B lymphocytes of newborn mice leads to defective Ig secretion in response to BAFF or APRIL.
Kanswal S; Katsenelson N; Selvapandiyan A; Bram RJ; Akkoyunlu M
J Immunol; 2008 Jul; 181(2):976-90. PubMed ID: 18606649
[TBL] [Abstract][Full Text] [Related]
7. The rGel/BLyS fusion toxin specifically targets malignant B cells expressing the BLyS receptors BAFF-R, TACI, and BCMA.
Lyu MA; Cheung LH; Hittelman WN; Marks JW; Aguiar RC; Rosenblum MG
Mol Cancer Ther; 2007 Feb; 6(2):460-70. PubMed ID: 17267661
[TBL] [Abstract][Full Text] [Related]
8. Transmembrane activator, calcium modulator, and cyclophilin ligand interactor drives plasma cell differentiation in LPS-activated B cells.
Ozcan E; Garibyan L; Lee JJ; Bram RJ; Lam KP; Geha RS
J Allergy Clin Immunol; 2009 Jun; 123(6):1277-86.e5. PubMed ID: 19427685
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of TACI-Ig on rat with adjuvant arthritis.
Wang D; Chang Y; Wu Y; Zhang L; Yan S; Xie G; Qin Q; Jin J; Wang W; Fang J; Wei W
Clin Exp Immunol; 2011 Feb; 163(2):225-34. PubMed ID: 21155990
[TBL] [Abstract][Full Text] [Related]
10. Protection against Pneumococcal colonization and fatal pneumonia by a trivalent conjugate of a fusion protein with the cell wall polysaccharide.
Lu YJ; Forte S; Thompson CM; Anderson PW; Malley R
Infect Immun; 2009 May; 77(5):2076-83. PubMed ID: 19255193
[TBL] [Abstract][Full Text] [Related]
11. [Immunoprotective effect of combined pneumococcal endopeptidase O and pneumococcal surface adhesin A vaccines against Streptococcus pneumoniae infection].
Zhang J; Cui YL; Jiang YM
Zhongguo Dang Dai Er Ke Za Zhi; 2017 May; 19(5):583-589. PubMed ID: 28506354
[TBL] [Abstract][Full Text] [Related]
12. The role of BLyS/BLyS receptors in anti-chromatin B cell regulation.
Hondowicz BD; Alexander ST; Quinn WJ; Pagán AJ; Metzgar MH; Cancro MP; Erikson J
Int Immunol; 2007 Apr; 19(4):465-75. PubMed ID: 17369193
[TBL] [Abstract][Full Text] [Related]
13. APRIL/BLyS Blockade Reduces Donor-specific Antibodies in Allosensitized Mice.
Wilson NA; Bath NM; Verhoven BM; Ding X; Boldt BA; Sukhwal A; Zhong W; Panzer SE; Redfield RR
Transplantation; 2019 Jul; 103(7):1372-1384. PubMed ID: 30830041
[TBL] [Abstract][Full Text] [Related]
14. Desensitization and treatment with APRIL/BLyS blockade in rodent kidney transplant model.
Bath NM; Ding X; Wilson NA; Verhoven BM; Boldt BA; Sukhwal A; Reese SR; Panzer SE; Djamali A; Redfield RR
PLoS One; 2019; 14(2):e0211865. PubMed ID: 30735519
[TBL] [Abstract][Full Text] [Related]
15. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L
Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388
[TBL] [Abstract][Full Text] [Related]
16. TACI-Ig induces immune balance of Th cells in MLN via BLyS/APRIL-receptors signaling in rats with adjuvant-induced arthritis.
Qin Q; Chang Y; Wang D; Wu Y; Zhang LL; Wei W
Int Immunopharmacol; 2011 Dec; 11(12):2167-75. PubMed ID: 21996540
[TBL] [Abstract][Full Text] [Related]
17. Protective antiviral antibody responses in a mouse model of influenza virus infection require TACI.
Wolf AI; Mozdzanowska K; Quinn WJ; Metzgar M; Williams KL; Caton AJ; Meffre E; Bram RJ; Erickson LD; Allman D; Cancro MP; Erikson J
J Clin Invest; 2011 Oct; 121(10):3954-64. PubMed ID: 21881204
[TBL] [Abstract][Full Text] [Related]
18. Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen a protects mice against nasopharyngeal colonization by Streptococcus pneumoniae.
Xu J; Dai W; Wang Z; Chen B; Li Z; Fan X
Clin Vaccine Immunol; 2011 Jan; 18(1):75-81. PubMed ID: 21047997
[TBL] [Abstract][Full Text] [Related]
19. Expression, purification, and characterization of pneumococcal PsaA-PspA fusion protein.
Guo X; Sun Q; Xi H; Zhang Y; Guo M; Zhang C; Zhu S; Gu T; Kong W; Wu Y
Protein Expr Purif; 2021 Feb; 178():105782. PubMed ID: 33122039
[TBL] [Abstract][Full Text] [Related]
20. Mucosal immunization with PsaA protein, using chitosan as a delivery system, increases protection against acute otitis media and invasive infection by Streptococcus pneumoniae.
Xu JH; Dai WJ; Chen B; Fan XY
Scand J Immunol; 2015 Mar; 81(3):177-85. PubMed ID: 25565478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
